A Study of Denufosol Tetrasodium Intravitreal Injection in Subjects With Post Cataract Extraction Macular Edema

NCT00135655 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Macular Edema, Cystoid

Interventions

DRUG: denufosol tetrasodium (INS37217) Intravitreal Injection

Sponsor

Merck Sharp & Dohme LLC